| 30904 |
Other |
EORTC-30904 |
ECOG |
CL |
1/13/2003 |
1 |
0 |
0 |
0 |
|
| 62933 |
Sarcoma |
62933 |
EORTC |
CL |
6/30/2000 |
1 |
0 |
0 |
0 |
EORTC is Coordinating Group |
| 89803 |
Gastrointestinal |
C89803 |
CALGB |
CL |
5/15/2001 |
1 |
|
0 |
0 |
|
| 91025 |
Lung Non-Small Cell |
|
MDA |
CL |
3/20/1997 |
0 |
1 |
0 |
0 |
1.0 CREDIT FOR YEAR ONE; 0.3 Followup Credit FOR EACH ADDITIONAL YEAR |
| 91140 |
Melanoma |
|
MSK |
CL |
12/29/1997 |
1 |
0 |
0 |
0 |
|
| C0187 |
Descriptive |
|
|
Closed |
11/30/1989 |
0 |
0.1 |
|
|
|
| C0190 |
Descriptive |
|
|
Closed |
4/29/1993 |
0 |
0.5 |
|
|
|
| C0191 |
Intervention Study |
|
|
Closed |
4/28/1995 |
0 |
0.5 |
|
|
|
| C0287 |
Pilot Study |
|
|
Closed |
11/30/1989 |
0 |
0 |
|
|
|
| C0290 |
Descriptive |
EST-C-00 |
|
Closed |
12/24/1992 |
0 |
1 |
|
|
|
| C0387 |
Pilot Study |
|
|
Closed |
8/1/1989 |
0 |
0.7 |
|
|
|
| C0390 |
Descriptive |
|
|
Closed |
4/29/1994 |
0 |
0.1 |
|
|
|
| C0488 |
Pilot Study |
|
|
Closed |
11/26/1991 |
0 |
0.1 |
|
|
|
| C0587 |
Descriptive |
|
|
Closed |
7/1/1990 |
0 |
0 |
|
|
|
| C0590 |
Intervention Study |
|
|
Closed |
1/15/1999 |
0 |
1 |
0.3 |
|
1.0 CREDIT FOR YEAR 1; 0.3 CREDIT FOR ADD'L YRS |
| C0687 |
Descriptive |
|
|
Closed |
1/16/1990 |
0 |
0.5 |
|
|
|
| C8984 |
Gastrointestinal |
|
|
CL |
10/15/1995 |
1 |
0 |
0 |
0 |
|
| C9011 |
Leukemia, Chronic |
|
CALGB |
CL |
|
1 |
0 |
0 |
0 |
|
| C9254 |
Other |
|
CALGB |
CL |
3/18/1997 |
1 |
0 |
0 |
0 |
|
| C9270 |
Gastrointestinal |
CALGB-9270 |
CALGB |
CL |
1/3/2000 |
0 |
1 |
0 |
0 |
1 CREDIT FOR YEAR ONE; 0.3 Followup Credit FOR EACH ADDITIONAL YEAR. |
| C9343 |
Breast |
CALGB-9343 |
CALGB |
CL |
2/26/1999 |
1 |
0 |
0 |
0 |
|
| C9344 |
Breast |
INT-0148 |
CALGB |
CL |
4/15/1997 |
1 |
0 |
0 |
0 |
|
| C9480 |
Genitourinary |
INT-0159 |
CALGB |
CL |
7/15/1998 |
1 |
0.5 |
0 |
0 |
0.5 CC CREDIT FOR QOL |
| C9481 |
Gastrointestinal |
C9481 |
CALGB |
CL |
12/29/2000 |
1 |
0.5 |
0 |
0 |
|
| C95-0001 |
Multiple Myeloma |
|
URCC |
AC |
|
0 |
1 |
0 |
0 |
Credit increased from 0.5 to 1.0 CC credit as of June 1, 2000 |
| C9581 |
Gastrointestinal |
C9581 |
CALGB |
CL |
5/31/2002 |
1.1 |
0 |
0 |
0 |
0.1 CREDIT FOR MARKER STUDY |
| C9732 |
Lung |
C9732 |
CALGB |
CL |
7/13/2001 |
1 |
0 |
0 |
0 |
|
| C9741 |
Breast |
C9741 |
CALGB |
CL |
3/31/1999 |
1 |
0 |
0 |
0 |
|
| C9781 |
Other |
|
CALGB |
CL |
3/30/2000 |
1 |
0 |
0 |
0 |
|
| CALGB-10404 |
Leukemia, Chronic |
CALGB-10404 |
CALGB |
AC |
|
1 |
0 |
0 |
0 |
|
| CALGB-80403 |
Gastrointestinal |
CALGB-80403 |
CALGB |
AC |
|
1 |
0 |
0 |
0 |
|
| CALGB-9710 |
Leukemia, Acute |
CALGB-9170 |
CALGB |
CL |
3/29/2005 |
1 |
0 |
0 |
0 |
|
| E1100 |
Breast |
|
ECOG |
CL |
8/25/2004 |
1 |
|
0 |
0 |
|
| E1103 |
Breast |
|
ECOG |
CL |
4/17/2006 |
1 |
0 |
0 |
0 |
|
| E1104 |
Breast |
|
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1105 |
Breast |
E1105 |
ECOG |
AC |
|
1 |
0.5 |
0 |
0 |
0.5 Cancer Control credit for QOL |
| E1189 |
Breast |
INT-0104 |
|
CL |
2/15/1995 |
0.1 |
0 |
0 |
0 |
|
| E1193 |
Intervention Study |
|
|
Closed |
9/29/1995 |
1 |
0.5 |
|
|
|
| E1194 |
Breast |
|
ECOG |
CL |
10/6/1995 |
1 |
0 |
0 |
0 |
|
| E1195 |
Breast |
|
ECOG |
CL |
2/9/2001 |
1 |
0 |
0 |
0 |
|
| E1196 |
Breast |
|
ECOG |
CL |
6/26/1997 |
1 |
0 |
0 |
0 |
|
| E1199 |
Breast |
E1199 |
ECOG |
CL |
1/15/2002 |
1 |
|
0 |
0 |
|
| E1200 |
Gastrointestinal |
|
ECOG |
CL |
7/27/2005 |
1 |
0 |
0 |
0 |
|
| E1201 |
Gastrointestinal |
|
ECOG |
CL |
10/19/2004 |
1 |
|
0 |
0 |
|
| E1202 |
Hepatic |
|
ECOG |
CL |
8/4/2004 |
1 |
|
0 |
0 |
|
| E1203 |
Hepatic |
|
ECOG |
CL |
8/5/2005 |
1 |
0 |
0 |
0 |
|
| E1290 |
Gastrointestinal |
|
|
CL |
1/3/1996 |
1 |
0 |
0 |
0 |
|
| E1292 |
Gastrointestinal |
INT-0136 |
ECOG |
CL |
5/19/2000 |
1 |
0 |
0 |
0 |
|
| E1293 |
Gastric |
|
ECOG |
CL |
3/24/1995 |
1 |
0 |
0 |
0 |
|
| E1294 |
Gastrointestinal |
|
ECOG |
CL |
9/12/2001 |
0.1 |
0 |
0 |
0 |
|
| E1295 |
Intervention Study |
|
|
Closed |
5/19/2000 |
0 |
0.5 |
|
|
|
| E1296 |
Gastrointestinal |
|
ECOG |
CL |
1/31/2001 |
1 |
0 |
0 |
0 |
|
| E1297 |
Gastrointestinal |
|
ECOG |
CL |
9/24/2003 |
1 |
|
0 |
0 |
|
| E1298 |
Gastrointestinal |
|
ECOG |
CL |
5/19/2000 |
1 |
0 |
0 |
0 |
|
| E1299 |
Gastrointestinal |
|
ECOG |
CL |
7/25/2001 |
1 |
|
0 |
0 |
|
| E1301 |
Head and Neck |
E1301 |
ECOG |
CL |
12/20/2004 |
1 |
0 |
0 |
0 |
|
| E1302 |
Head and Neck |
E1302 |
ECOG |
AC |
|
1 |
0.5 |
0 |
0 |
Cancer Control credit for QOL |
| E1303 |
Head and Neck |
|
ECOG |
CL |
2/27/2006 |
1 |
|
0 |
0 |
|
| E1304 |
Head and Neck |
|
ECOG |
AC |
|
1 |
|
0 |
0 |
|
| E1390 |
Head and Neck |
|
|
CL |
11/24/1992 |
1 |
0 |
0 |
0 |
|
| E1392 |
Head and Neck |
INT-0126 |
ECOG |
CL |
11/29/1999 |
1 |
0 |
0 |
0 |
|
| E1393 |
Head and Neck |
|
|
CL |
6/15/1995 |
1 |
0 |
0 |
0 |
|
| E1394 |
Head and Neck |
|
ECOG |
CL |
8/8/2000 |
1 |
0 |
0 |
0 |
|
| E1395 |
Head and Neck |
E1395 |
ECOG |
CL |
1/12/2000 |
1 |
0 |
0 |
0 |
NO CREDIT FOR QOL-TOXICITY ASSESS. |
| E1402 |
Lymphomas |
|
ECOG |
CL |
10/10/2007 |
1 |
0 |
0 |
0 |
|
| E1404 |
Lymphomas Non-Hodgkin's |
|
ECOG |
CL |
9/25/2007 |
1 |
0 |
0 |
0 |
|
| E1405 |
Other |
|
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1485 |
Leukemia, Acute |
|
|
CL |
2/24/1998 |
0 |
0.2 |
0 |
0 |
|
| E1489 |
Lymphomas Non-Hodgkin's |
|
|
CL |
2/24/1995 |
1 |
0 |
0 |
0 |
|
| E1490 |
Leukemia, Acute |
|
|
CL |
11/24/1992 |
1 |
0 |
0 |
0 |
|
| E1492 |
Lymphomas, Hodgkin's Disease |
|
|
CL |
2/8/1995 |
1 |
0 |
0 |
0 |
|
| E1493 |
Lymphomas |
|
ECOG |
CL |
4/15/1997 |
1 |
0 |
0 |
0 |
|
| E1494 |
Lymphomas Non-Hodgkin's |
|
ECOG |
CL |
6/17/1999 |
1 |
0 |
0 |
0 |
|
| E1495 |
Lymphomas |
|
ECOG |
CL |
4/22/1999 |
1 |
0 |
0 |
0 |
|
| E1496 |
Lymphomas |
E1496 |
ECOG |
CL |
5/2/2003 |
1 |
0 |
0 |
0 |
|
| E1497 |
Lymphomas Non-Hodgkin's |
|
ECOG |
CL |
11/15/2002 |
1 |
0 |
0 |
0 |
|
| E1499 |
Lymphomas |
|
ECOG |
CL |
2/28/2005 |
1 |
0 |
0 |
0 |
|
| E1500 |
Lung Non-Small Cell |
|
ECOG |
CL |
12/9/2003 |
1 |
|
0 |
0 |
|
| E1501 |
Lung Non-Small Cell |
|
ECOG |
CL |
2/28/2003 |
1 |
|
0 |
0 |
|
| E1503 |
Lung |
|
ECOG |
CL |
8/22/2005 |
1 |
0 |
0 |
0 |
|
| E1504 |
Lung |
|
ECOG |
AC |
|
1 |
|
0 |
0 |
|
| E1505 |
Lung Non-Small Cell |
E1505 |
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1506 |
Lung |
|
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1594 |
Lung Non-Small Cell |
|
ECOG |
CL |
5/17/1999 |
1 |
0 |
0 |
0 |
|
| E1597 |
Lung Non-Small Cell |
|
ECOG |
CL |
9/4/1998 |
1 |
0 |
0 |
0 |
|
| E1599 |
Lung Non-Small Cell |
|
ECOG |
CL |
11/20/2002 |
1 |
|
0 |
0 |
|
| E1602 |
Melanoma |
|
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1603 |
Melanoma |
|
ECOG |
CL |
5/17/2006 |
1 |
0 |
0 |
0 |
|
| E1690 |
Melanoma |
|
|
CL |
6/1/1995 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY APPROVAL; 1.0 CREDIT THRU 5/31/91; 1.5 STARTING 6/1/91 |
| E1694 |
Melanoma |
E1694 |
ECOG |
CL |
10/15/1999 |
1 |
0 |
0 |
0 |
|
| E1695 |
Melanoma |
E1695 |
ECOG |
CL |
10/15/1999 |
0.1 |
0 |
0 |
0 |
MARKER STUDY IN CONTEXT OF E1695 GM2-KLH/QS-21 VACCINE VS INTERFERON ALFA-2B |
| E1696 |
Melanoma |
|
ECOG |
CL |
5/14/2003 |
1 |
|
0 |
0 |
|
| E1697 |
Melanoma |
E1697 |
ECOG |
AC |
|
1 |
0.5 |
0 |
0 |
0.5 CC CREDIT IS FOR QOL |
| E1793 |
Sarcoma |
|
ECOG |
CL |
9/27/2000 |
1 |
0 |
0 |
0 |
|
| E1794 |
Sarcoma |
|
ECOG |
CL |
5/5/2000 |
1 |
0 |
0 |
0 |
|
| E1797 |
Sarcoma |
|
ECOG |
CL |
5/5/2000 |
1 |
0 |
0 |
0 |
|
| E1802 |
Genitourinary |
|
ECOG |
CL |
10/21/2003 |
1 |
0.3 |
0 |
0 |
0.3 CC Credit for QOL component |
| E1804 |
Genitourinary |
|
ECOG |
CL |
12/14/2007 |
1 |
0 |
0 |
0 |
|
| E1887 |
Genitourinary |
INT-0080 |
SWOG |
CL |
7/1/1998 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY APPROVAL |
| E1889 |
Genitourinary |
|
|
CL |
11/4/1992 |
1 |
0 |
0 |
0 |
|
| E1893 |
Genitourinary |
|
ECOG |
CL |
6/2/1995 |
1 |
0 |
0 |
0 |
|
| E1896 |
Genitourinary |
|
ECOG |
CL |
6/19/1998 |
1 |
0 |
0 |
0 |
|
| E1897 |
Genitourinary |
|
ECOG |
CL |
5/18/2001 |
1 |
0.5 |
0 |
0 |
0.5 CC CREDIT FOR QOL |
| E1898 |
Genitourinary |
|
ECOG |
CL |
12/15/2000 |
1 |
0.5 |
0 |
0 |
0.5 CC CRD FOR QOL |
| E1899 |
Genitourinary |
E1899 |
ECOG |
CL |
12/28/2004 |
1 |
0.3 |
0 |
0 |
0.3 cc credit for QOL |
| E1900 |
Leukemia, Acute |
E1900 |
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1902 |
Other |
|
ECOG |
AC |
|
1 |
|
0 |
0 |
|
| E1904 |
Leukemia, Acute |
|
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1905 |
Leukemia, Acute |
E1905 |
ECOG |
AC |
|
1 |
0 |
0 |
0 |
|
| E1989 |
Instrument Development |
|
|
Closed |
1/21/1992 |
0 |
0.5 |
|
|
|
| E1990 |
Other |
|
|
CL |
2/1/1996 |
0 |
|